Ortho-novum 1/35-21 / ethinyl estradiol; norethindrone NDA 017489 international drug patent coverage, generic alternatives and manufacturers

Generated: August 16, 2017

NDA 017489 describes ORTHO-NOVUM 1/35-21, which is a drug marketed by Ortho Mcneil Pharm and is included in one NDA. Additional details are available on the ORTHO-NOVUM 1/35-21 profile page.

The generic ingredient in ORTHO-NOVUM 1/35-21 is ethinyl estradiol; norethindrone. There are twenty-six drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone profile page.

Summary for NDA: 017489

Tradename:	1
Applicant:	1
Ingredient:	1
Patents:	0
Formulation / Manufacturing:	see details

Summary for product number 002

Active Rx/OTC/Discontinued:	DISCN	Dosage:	TABLET;ORAL-21			Strength	0.035MG;1MG
Approval Date:	Approved Prior to Jan 1, 1982	TE:		RLD:	No

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.